An interventional study of Supportive-expressive group therapy in Breast Neoplasms and Breast Cancer, sponsored by Universidade do Porto. Status unknown at 1 site in Portugal. Open to female participants aged 30 Years to 65 Years. Per ClinicalTrials.gov, last updated 2016-10-17.
Sponsored by Universidade do Porto · Not applicable, Interventional, and Supportive care
To test the feasibility of supportive-expressive group intervention (SEGT) for women with primary breast cancer and to provide a preliminary test of its efficacy.
This study aims to compare the efficacy of a 16-sessions group intervention (Supportive-Expressive group therapy) versus control group (no intervention) in women with primary breast cancer.
This study tries to evaluate the efficacy of SEGT on breast cancer patients' emotion regulation, social support, caregiving, and marital satisfaction, and its improvement on breast cancer patients' life quality. This study also intents to explore the moderating role of attachment on these associations.
12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.
This study's planned enrollment of 50 is below the median of 72 across 9,303 interventional studies indexed under Breast Neoplasms.
Browse Breast Neoplasms studies →Universidade do Porto is the lead sponsor of 170 studies on the registry; 52 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
16 weekly sessions, 90 min of Supportive-expressive group therapy
Other: Supportive-expressive group therapy
No intervention
The supportive-expressive group therapy (SEGT) is an intervention for women with BC that is designed to build bonds and to facilitate changes in emotional expression and regulation taking into account the role that emotions play in physiologic function, intimately related to the progression of the disease. It is based on seven main themes: building bonds, expressing feelings, detoxifying dying, reordering life priorities, improve support from and communication with family and friends, fortifying families, dealing with doctors, and control pain and anxiety. Although originally developed according to an existential perspective, recently the supportive-expressive group therapy has been used according to an attachment framework.
Also known as: SEGT
Change in quality of life across time
The World Health Organization Quality of Life - BREF
Time frame: T0 - before the intervention; T1 - 2 months later; T2 - 4 months later; T3 - 10 months later
Change in emotion suppression across time
The Emotion Regulation Questionnaire
Time frame: T0 - before the intervention; T1 - 2 months later; T2 - 4 months later; T3 - 10 months later
Change in emotional self-efficacy across time
The Stanford Emotional Self-Efficacy Scale-Cancer
Time frame: T0 - before the intervention; T1 - 2 months later; T2 - 4 months later; T3 - 10 months later
Change in cognitive emotion across time
The Cognitive Emotion Regulation Questionnaire
Time frame: T0 - before the intervention; T1 - 2 months later; T2 - 4 months later; T3 - 10 months later
Change in social support across time
The Multidimensional Scale of Perceived Social Support
Time frame: T0 - before the intervention; T1 - 2 months later; T2 - 4 months later; T3 - 10 months later
Change in caregiving across time
The Caregiving Questionnaire
Time frame: T0 - before the intervention; T1 - 2 months later; T2 - 4 months later; T3 - 10 months later
Change in marital relationship across time
Relationship Assessment Scale
Time frame: T0 - before the intervention; T1 - 2 months later; T2 - 4 months later; T3 - 10 months later
Change in group climate across time
The Group Climate Questionnaire
Time frame: T1 - 2 months later; T2 - 4 months later; T3 - 10 months later
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Oct 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidade do Porto